EU Approves Epidyolex to Treat Severe Epilepsy in Children Martin Green·September 23, 2019The EU has broken new ground by approving Epidyolex in order to help doctors across Europe treat children...Marijuana Politics·0 Comments·
Earnings Update: Second GW Pharmaceuticals Stock Price Increase After February’s Alzheimer’s Trial News Martin Green·February 15, 2019GW Pharmaceuticals (GWPH) saw its share price increase again after releasing earnings, this followed a February spike after...Marijuana News·0 Comments·
Epidiolex Maker GW Pharmaceuticals Raises $345 Million Through Share Sale Martin Green·October 10, 2018GW Pharmaceuticals (NASDAQ: GWPH), maker of the epilepsy treatment Epidiolex, has raised $345 million to fund an expansion...Marijuana News·1 Comment·
Marijuana News – Weekly Investor Roundup (August 11th) Scott Willis·August 11, 2018Marijuana News: Why Germany is going to dissapoint investors and producers, Heineken introduces first mainstream infused beverage and...Marijuana News·0 Comments·
Marijuana News: Weekly Investor Roundup (June 23rd) Scott Willis·June 23, 2018Marijuana News: Cannabis legalization date confirmed. First FDA approval of a marijuana drug may be days away, Jamaica...Marijuana News·2 Comments·
Marijuana News: Weekly Investor Roundup (June 15th) Scott Willis·June 16, 2018Marijuana News: Cannabis legalization likely slips to late September. German medical patient numbers revealed, how to invest in...Marijuana News·0 Comments·
Investing in Medical Marijuana Stocks – Quantifying the Upside Scott Willis·June 15, 2018Epilepsy treatment is a $6 billion opportunity for the Marijuana industry. This report explores how to invest in...Marijuana Analysis·14 Comments·
